Össur has introduced two new products to its Miami brand of braces: the Miami J Select Cervical Collar for people who require gross immobilization of the cervical spine, and the Miami TLSO advanced spinal compression support system for patients requiring gross spinal immobilization up to T7.
ÖSSUR Adds to Miami Spine Bracing Product Line

Jason Thorne, VP of Global Marketing for Össur, told OTW, “The Miami brand includes products that cover the full spine spectrum from the cervical spine to sacrum and were built upon decades of experience in design.”
“Our goals with the launches of Miami J Select and Miami TLSO were to provide the comfort, immobilization and quality expected from the brand.”
“With the Miami J Select, the product includes patient compliance features, such as the locking mechanism, to ensure patients do not tamper with the clinically prescribed levels of collar height and Blue is You intuitive patient touch points, simplifying patient education. Regarding the Miami TLSO, the product also includes the Blue is You touchpoints, as well as a modular panel system to accommodate patient support needs with their prescribed level of immobilization.”
“The development of the Miami TLSO included gathering continuous input from clinical experts throughout the process.”
“One of the goals of the project was to address the needs of patients and practitioners, while simplifying the application without compromising on the fit or performance. There were many sessions to gather key practitioner feedback to ensure the ease-of-use and adjustability goals were going to exceed expectations. Also, it was key for the design to incorporate touchpoints for intuitive patient education and is why the Blue is You components were added to the Quick-Release buckles and pulley system.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.